Dermira Inc (DERM)
$8.38 0.04 (0.48%)
17:04 EDT DERM Stock Quote Delayed 15 Minutes
Previous Close $8.38
Market Cap 350.69M
PE Ratio -1.03
Volume (Avg. Vol.) 444,500
Day's Range 8.23 - 8.48
52-Week Range 6.00 - 15.48
Dividend & Yield N/A (N/A)
DERM Stock Predictions, Articles, and Dermira Inc News
- From InvestorPlace
- From the Web
Government is scrutinizing the drug development and approval process and creating uncertainties among biotech stocks. Time to buy?
Dermira news concerning positive results from a recent Phase 2b study of lebrikizumab has DERM stock flying high on Monday.
Small biotech stocks can pack a wallop. Here are five biotech stocks that have prospects bigger than their share prices.
This week, the overall grades of 10 Pharmaceuticals stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
The grades of 11 Pharmaceuticals stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
The following stocks were moving the Manufacturing sector today.
3 Stocks to Watch on Thursday: Ciena Corporation (CIEN), Dermira Inc (DERM) and Joy Global Inc. (JOY)
Ciena (CIEN) and Joy Global (JOY) shoot higher on Street-beating results, while Dermira (DERM) is popping on positive trial news for its sweating treatment.
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
Bearish investors can find an opportunity in these biotech stocks as they look to continue a downward trend.
From Seeking Alpha
The Daily Biotech Pulse: Genfit NASH Drug In China, Conatus Explores Sale, Gilead Stitches Up Immuno-Oncology Partnership
From Market News Video
From The Street
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!